MITIGARE vs SULFINPYRAZONE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. MITIGARE and SULFINPYRAZONE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MITIGARE	SULFINPYRAZONE
Rating	72/100	70/100
Pharmacy pays	~$3.90 /30	—
Type	RX	RX
Active ingredient	COLCHICINE	SULFINPYRAZONE
Manufacturer	Hikma	Par Pharm
Dosage forms	Capsule	Tablet, Capsule
Drug class	Alkaloid	—
Boxed warning	None	None
Half-life	about 27 to 31 hours (the label gives mean elimination half-lives of 26.6 to 31.2 hours in young healthy volunteers on 0.6 mg twice daily)	—
Treats	Amyloidosis, Gout, Biliary Liver Cirrhosis	Angina Pectoris, Coronary Disease, Gout

mitigare sulfinpyrazone

Rating

72/100

70/100

Pharmacy pays

~$3.90 /30

—

Type

Active ingredient

COLCHICINE

SULFINPYRAZONE

Manufacturer

Hikma

Par Pharm

Dosage forms

Capsule

Tablet, Capsule

Drug class

Alkaloid

—

Boxed warning

None

Half-life

about 27 to 31 hours (the label gives mean elimination half-lives of 26.6 to 31.2 hours in young healthy volunteers on 0.6 mg twice daily)

—

Treats

Amyloidosis, Gout, Biliary Liver Cirrhosis

Angina Pectoris, Coronary Disease, Gout

Frequently asked questions

Which is better-rated, Mitigare or Sulfinpyrazone?

By our independent rating, Mitigare scores higher — 3.6 vs 3.5 out of 5 for Sulfinpyrazone. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Mitigare and Sulfinpyrazone?

Mitigare contains Colchicine, while Sulfinpyrazone contains Sulfinpyrazone — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.